DEPLOYDatabase

Partnership

UNC Chapel Hill x SAS Antiviral Drug Development Partnership

SAS and UNC Chapel Hill partnered to accelerate antiviral drug discovery through the Rapidly Emerging Antiviral Drug Development Initiative. SAS contributes AI and machine learning capabilities to advance drug discovery for future pandemic preparedness.

development · Active · operating


Machine-readable surfaces

aa6467ea-b81c-40c1-a4d8-bbdf5938f31b
Type
development
Status
Activeoperating

Who’s involved

Public research university in Chapel Hill, North Carolina, chartered in 1789. It began enrolling students in 1795, making it one of the oldest public universities in the United States.

HQChapel Hill, North Carolina, USAwww.unc.edu2 partnerships

Off-registry parties

  • SAS Institute · technology provider

Related partnerships

Other deals between the same parties

Recent partnerships of the same kind

Sources (1)

  1. https://uncnews.unc.edu/2021/09/14/sas-and-unc-chapel-hill-partner-to-accelerate-antiviral-drug-development/

Deploy Watch

Track this partnership.

We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.